MEDIROM HEALTHCARE TECHNOLOG (MRM) Fundamental Analysis & Valuation

NASDAQ:MRM • US58510H1032

1.31 USD
0 (0%)
At close: Mar 4, 2026
1.25 USD
-0.06 (-4.58%)
After Hours: 3/4/2026, 5:43:46 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This MRM fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to MRM. MRM was compared to 75 industry peers in the Diversified Consumer Services industry. MRM may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, MRM is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

3

1. MRM Profitability Analysis

1.1 Basic Checks

  • In the past year MRM was profitable.
  • In the past year MRM has reported a negative cash flow from operations.
  • In multiple years MRM reported negative net income over the last 5 years.
  • In the past 5 years MRM always reported negative operating cash flow.
MRM Yearly Net Income VS EBIT VS OCF VS FCFMRM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 -500M -1B -1.5B

1.2 Ratios

  • MRM has a Return On Assets (0.51%) which is in line with its industry peers.
  • With a decent Return On Equity value of 16.67%, MRM is doing good in the industry, outperforming 77.33% of the companies in the same industry.
Industry RankSector Rank
ROA 0.51%
ROE 16.67%
ROIC N/A
ROA(3y)1.91%
ROA(5y)-4.19%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MRM Yearly ROA, ROE, ROICMRM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400

1.3 Margins

  • MRM has a Profit Margin (0.50%) which is in line with its industry peers.
  • In the last couple of years the Profit Margin of MRM has grown nicely.
  • MRM's Operating Margin has declined in the last couple of years.
  • Looking at the Gross Margin, with a value of 25.05%, MRM is doing worse than 72.00% of the companies in the same industry.
  • In the last couple of years the Gross Margin of MRM has grown nicely.
Industry RankSector Rank
OM N/A
PM (TTM) 0.5%
GM 25.05%
OM growth 3YN/A
OM growth 5Y-50.92%
PM growth 3YN/A
PM growth 5Y32.28%
GM growth 3Y1.14%
GM growth 5Y2.16%
MRM Yearly Profit, Operating, Gross MarginsMRM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. MRM Health Analysis

2.1 Basic Checks

  • MRM does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for MRM has been increased compared to 1 year ago.
  • MRM has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for MRM is higher compared to a year ago.
MRM Yearly Shares OutstandingMRM Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
MRM Yearly Total Debt VS Total AssetsMRM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

  • Based on the Altman-Z score of 0.41, we must say that MRM is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of 0.41, MRM perfoms like the industry average, outperforming 41.33% of the companies in the same industry.
  • MRM has a Debt/Equity ratio of 5.53. This is a high value indicating a heavy dependency on external financing.
  • MRM's Debt to Equity ratio of 5.53 is on the low side compared to the rest of the industry. MRM is outperformed by 81.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 5.53
Debt/FCF N/A
Altman-Z 0.41
ROIC/WACCN/A
WACC2.26%
MRM Yearly LT Debt VS Equity VS FCFMRM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 1B -1B

2.3 Liquidity

  • A Current Ratio of 0.24 indicates that MRM may have some problems paying its short term obligations.
  • With a Current ratio value of 0.24, MRM is not doing good in the industry: 89.33% of the companies in the same industry are doing better.
  • A Quick Ratio of 0.21 indicates that MRM may have some problems paying its short term obligations.
  • The Quick ratio of MRM (0.21) is worse than 89.33% of its industry peers.
Industry RankSector Rank
Current Ratio 0.24
Quick Ratio 0.21
MRM Yearly Current Assets VS Current LiabilitesMRM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. MRM Growth Analysis

3.1 Past

  • MRM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 162.73%, which is quite impressive.
  • MRM shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 47.92% yearly.
  • The Revenue has grown by 14.26% in the past year. This is quite good.
  • MRM shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 16.25% yearly.
EPS 1Y (TTM)162.73%
EPS 3YN/A
EPS 5Y47.92%
EPS Q2Q%26.3%
Revenue 1Y (TTM)14.26%
Revenue growth 3Y15.33%
Revenue growth 5Y16.25%
Sales Q2Q%-6.67%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MRM Yearly Revenue VS EstimatesMRM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

More info and screens

Find the best growth stocksShow best growing peers

2

4. MRM Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 10.08 indicates a reasonable valuation of MRM.
  • Based on the Price/Earnings ratio, MRM is valued cheaply inside the industry as 82.67% of the companies are valued more expensively.
  • The average S&P500 Price/Earnings ratio is at 27.03. MRM is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 10.08
Fwd PE N/A
MRM Price Earnings VS Forward Price EarningsMRM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • MRM's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 19.77
MRM Per share dataMRM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.21
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. MRM Dividend Analysis

5.1 Amount

  • No dividends for MRM!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

MRM Fundamentals: All Metrics, Ratios and Statistics

MEDIROM HEALTHCARE TECHNOLOG

NASDAQ:MRM (3/4/2026, 5:43:46 PM)

After market: 1.25 -0.06 (-4.58%)

1.31

0 (0%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)05-20
Earnings (Next)N/A
Inst Owners2.08%
Inst Owner Change-88.79%
Ins Owners25.57%
Ins Owner ChangeN/A
Market Cap10.35M
Revenue(TTM)8.07B
Net Income(TTM)40.47M
Analysts0
Price TargetN/A
Short Float %0.48%
Short Ratio0.06
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 10.08
Fwd PE N/A
P/S 0.2
P/FCF N/A
P/OCF N/A
P/B 6.72
P/tB N/A
EV/EBITDA 19.77
EPS(TTM)0.13
EY9.92%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1.23
FCFYN/A
OCF(TTM)-0.72
OCFYN/A
SpS6.48
BVpS0.19
TBVpS-2.37
PEG (NY)N/A
PEG (5Y)0.21
Graham Number0.76
Profitability
Industry RankSector Rank
ROA 0.51%
ROE 16.67%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 0.5%
GM 25.05%
FCFM N/A
ROA(3y)1.91%
ROA(5y)-4.19%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5Y-50.92%
PM growth 3YN/A
PM growth 5Y32.28%
GM growth 3Y1.14%
GM growth 5Y2.16%
F-Score4
Asset Turnover1.01
Health
Industry RankSector Rank
Debt/Equity 5.53
Debt/FCF N/A
Debt/EBITDA 9
Cap/Depr 182.82%
Cap/Sales 7.84%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.24
Quick Ratio 0.21
Altman-Z 0.41
F-Score4
WACC2.26%
ROIC/WACCN/A
Cap/Depr(3y)216.74%
Cap/Depr(5y)157.89%
Cap/Sales(3y)7.57%
Cap/Sales(5y)5.14%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)162.73%
EPS 3YN/A
EPS 5Y47.92%
EPS Q2Q%26.3%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)14.26%
Revenue growth 3Y15.33%
Revenue growth 5Y16.25%
Sales Q2Q%-6.67%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y72.6%
EBIT growth 3YN/A
EBIT growth 5Y-42.95%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-22.06%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-110.8%
OCF growth 3YN/A
OCF growth 5YN/A

MEDIROM HEALTHCARE TECHNOLOG / MRM FAQ

What is the ChartMill fundamental rating of MEDIROM HEALTHCARE TECHNOLOG (MRM) stock?

ChartMill assigns a fundamental rating of 2 / 10 to MRM.


What is the valuation status of MEDIROM HEALTHCARE TECHNOLOG (MRM) stock?

ChartMill assigns a valuation rating of 2 / 10 to MEDIROM HEALTHCARE TECHNOLOG (MRM). This can be considered as Overvalued.


How profitable is MEDIROM HEALTHCARE TECHNOLOG (MRM) stock?

MEDIROM HEALTHCARE TECHNOLOG (MRM) has a profitability rating of 3 / 10.


Can you provide the PE and PB ratios for MRM stock?

The Price/Earnings (PE) ratio for MEDIROM HEALTHCARE TECHNOLOG (MRM) is 10.08 and the Price/Book (PB) ratio is 6.72.